| Annual Financials | 2020 | 2021 | TTM |
Revenue  | 544 | 508 | 0 |
| Expenses | 325 | 293 | 0 |
| EBITDA | 220 | 215 | 0 |
| Operating Profit % | 40 % | 41 % | 0 % |
| Depreciation | 18 | 20 | 0 |
| Interest | 7 | 5 | 0 |
| Profit Before Tax | 194 | 185 | 0 |
| Tax | 49 | 49 | 0 |
| Net Profit | 145 | 136 | 0 |
| EPS in ₹ | 1,462.60 | 1,396.27 | 0.00 |
Blue Jet Healthcare
Blue Jet Healthcare
624.05
+49.55
(8.62%)
Market Cap
10,825.11 Cr
PE Ratio
40.22
Volume
48,44,866.00
Day High - Low
630.00 - 596.00
52W High-Low
1,027.80 - 325.00
Key Fundamentals
Market Cap
10,825.11 Cr
EPS
1,396.27
PE Ratio
40.22
PB Ratio
7.33
Book Value
78.40
EBITDA
214.90
Dividend Yield
0.21 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
39.96
Debt to Equity
0.24
Analyst Rating and Forecast
- By Refinitiv from5 analysts
Actual
Company News
View All News
Blue Jet Healthcare opened a Qualified Institutions Placement on July 6, 2026, with a floor price of ₹531.70 per share. The issue follows approvals from the Board and shareholders.
Blue Jet Healthcare reported an 18.8% decline in net profit to ₹2,478.16 million for FY26, while revenue from operations decreased 7.9% to ₹9,423.67 million. The Board approved the audited financial statements on May 25, 2026.
Blue Jet Healthcare approves fund raising
Jun 17, 2026
Jun 17, 2026Blue Jet Healthcare approved raising funds via equity shares or securities at its EGM on June 17, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,935.50 | #1 4,64,391.28 | 40.42 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 69.33 | |
6,836.00 | 1,81,474.32 | 70.42 | 10,560.00 | 8.73 | 2,520 | 13.44 | 57.88 | |
4,901.50 | 1,65,889.03 | 77.50 | 13,886.20 | 20.34 | 2,138 | -26.91 | 76.03 | |
1,439.40 | 1,16,281.25 | 30.16 | 29,044.60 | 2.24 | 3,870 | -55.32 | 56.29 | |
1,150.80 | 1,15,797.41 | 22.58 | 26,719.70 | 13.65 | 5,242 | 7.82 | 65.75 | |
2,496.30 | 1,14,138.96 | #1 21.37 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 68.54 | |
2,525.10 | 1,04,285.61 | 53.94 | 14,277.60 | 12.03 | 1,750 | 31.75 | 58.02 | |
1,244.30 | 1,03,857.87 | 25.49 | 35,058.60 | 3.90 | 4,158 | -86.05 | 35.49 | |
1,564.70 | 90,029.38 | 26.31 | 33,384.70 | 3.21 | 3,376 | 1.99 | 56.89 | |
1,537.80 | 83,019.15 | 91.21 | 6,867.80 | #1 22.01 | 890 | 21.18 | 64.70 |
Growth Rate
Revenue Growth
-6.62 %
Net Income Growth
-6.34 %
Cash Flow Change
5.34 %
ROE
-44.11 %
ROCE
-38.82 %
EBITDA Margin (Avg.)
4.83 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2020 | 2021 |
| Total Assets | 375 | 536 |
| Fixed Assets | 107 | 139 |
| Current Assets | 249 | 390 |
| Capital Work in Progress | 2 | 3 |
| Investments | 34 | 37 |
| Other Assets | 233 | 358 |
| Total Equity & Liabilities | 375 | 536 |
| Current Liabilities | 133 | 163 |
| Non Current Liabilities | 39 | 33 |
| Total Equity | 203 | 340 |
| Reserve & Surplus | 182 | 320 |
| Share Capital | 1 | 10 |
Cash Flow
| Cash Flow | 2020 | 2021 |
| Net Cash Flow | 5 | 51 |
| Investing Activities | -45 | -51 |
| Operating Activities | 123 | 129 |
| Financing Activities | -73 | -28 |
Share Holding
| % Holding | Sept 2022 | Oct 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 100.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 86.00 % | 79.81 % | 79.81 % | 79.81 % | 79.81 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 2.01 % | 2.02 % | 2.18 % | 1.10 % | 2.29 % | 1.97 % | 1.82 % | 1.14 % | 0.88 % | 0.40 % |
| DIIs | 0.00 % | 3.32 % | 2.81 % | 3.03 % | 2.14 % | 1.74 % | 2.02 % | 1.33 % | 0.94 % | 3.63 % | 4.65 % | 4.51 % | 4.65 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 6.97 % | 4.73 % | 5.36 % | 5.79 % | 5.90 % | 6.30 % | 7.28 % | 8.03 % | 9.78 % | 9.91 % | 10.60 % | 11.01 % |
| Others | 0.00 % | 3.71 % | 6.46 % | 3.60 % | 4.04 % | 4.17 % | 4.57 % | 3.10 % | 3.05 % | 4.95 % | 4.50 % | 4.20 % | 4.12 % |
| No of Share Holders | 7 | 2,03,777 | 55,589 | 48,625 | 42,882 | 41,933 | 43,003 | 54,581 | 70,772 | 80,117 | 80,187 | 79,199 | 78,917 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 1.2 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.11 | 0.37 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 18 Sept 2024 |  Dividend | ₹ 1.00 /share | 17 Sept 2024 | 375.60 | 526.85 |
| 25 Sept 2024 |  Annual General Meeting | NA | 25 Sept 2024 | 517.20 | 537.80 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 473.65 | 480.30 |
| 29 Jan 2025 | Quarterly Result Announcement | NA | 29 Jan 2025 | 581.00 | 572.95 |
| 14 May 2025 | Quarterly Result Announcement | NA | 14 May 2025 | 723.30 | 769.30 |
| 22 Jul 2025 | Quarterly Result Announcement | NA | 22 Jul 2025 | 955.20 | 1,006.80 |
| 19 Sept 2025 | Dividend | ₹ 1.20 /share | 19 Sept 2025 | 769.30 | 683.55 |
| 26 Sept 2025 | Annual General Meeting | NA | 26 Sept 2025 | 770.70 | 664.85 |
| 04 Nov 2025 | Quarterly Result Announcement | NA | 04 Nov 2025 | 638.55 | 674.75 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 406.70 | 441.60 |
| 25 May 2026 | Quarterly Result Announcement | NA | 25 May 2026 | 421.05 | 441.05 |
| 17 Jun 2026 |  Extraordinary General Meeting | NA | 17 Jun 2026 | 482.50 | 510.40 |
Announcements
Announcement under Regulation 30 (LODR)-Qualified Institutional Placement2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Qualified Institutional Placement2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Qualified Institutional Placement5 days ago
5 days agoAudited Standalone Financial Statement For The Financial Year Ended March 31 20265 days ago
5 days agoAnnouncement under Regulation 30 (LODR)-Resignation of Statutory Auditors5 days ago
5 days agoClosure of Trading WindowJun 25, 2026
Jun 25, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJun 18, 2026
Jun 18, 2026Shareholder Meeting / Postal Ballot-Outcome of EGMJun 17, 2026
Jun 17, 2026Clarification On Volume MovementJun 12, 2026
Jun 12, 2026Clarification sought from Blue Jet Healthcare LtdJun 12, 2026
Jun 12, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 29, 2026
May 29, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 27, 2026
May 27, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2026
May 27, 2026Notice Of Extra-Ordinary General Meeting Of Blue Jet Healthcare LimitedMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 25, 2026
May 25, 2026Corporate Action-Board approves DividendMay 25, 2026
May 25, 2026Financial Results For March 31 2026May 25, 2026
May 25, 2026Board Meeting Outcome for Outcome Of Board MeetingMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 19, 2026
May 19, 2026Board Meeting Intimation for As Per Attached PdfMay 19, 2026
May 19, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Apr 08, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 12, 2026
Mar 12, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 28, 2026
Feb 28, 2026Company UpdateFeb 19, 2026
Feb 19, 2026Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 14, 2026
Feb 14, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2026
Feb 14, 2026Announcement under Regulation 30 (LODR)-Investor PresentationFeb 13, 2026
Feb 13, 2026Outcome Of Board MeetingFeb 13, 2026
Feb 13, 2026Board Meeting Outcome for Outcome Of Board MeetingFeb 13, 2026
Feb 13, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 06, 2026
Feb 06, 2026Board Meeting Intimation for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 06, 2026
Feb 06, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 06, 2026
Jan 06, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Announcement under Regulation 30 (LODR)-Credit RatingDec 17, 2025
Dec 17, 2025Update On Implementation Of 1.0 Of SAP S/4HANA By Blue Jet Healthcare LimitedDec 09, 2025
Dec 09, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 08, 2025
Nov 08, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 05, 2025
Nov 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Investor PresentationNov 04, 2025
Nov 04, 2025Unaudited Financial Result For The Quarter And Half Year Ended September 30 2025Nov 04, 2025
Nov 04, 2025Board Meeting Outcome for Unaudited Standalone Financial Result For The Quarter And Half Year Ended Sep 2025Nov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 29, 2025
Oct 29, 2025Board Meeting Intimation for Approval Of The Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025 Along With Limited Review Report As Received From The Statutory Auditor Of The CompanyOct 29, 2025
Oct 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Mutual Fund Holdings
Technical Indicators
RSI(14)
Neutral 75.11
ATR(14)
Volatile 26.55
STOCH(9,6)
Overbought 80.72
STOCH RSI(14)
Neutral 62.79
MACD(12,26)
Bullish 5.56
ADX(14)
Very Strong Trend 51.99
UO(9)
Bearish 57.23
ROC(12)
Uptrend And Accelerating 21.25
WillR(14)
Overbought -4.91
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
